Introduction
FXIII is a transglutaminase (TG) that circulates in plasma as a heterotetramer A 2 B 2 composed of two catalytic A and two regulatory B subunits (Muszbek et al., 1999; Lorand and Graham, 2003) . It becomes activated by Ca 2+ and thrombin at the final stage of blood coagulation, crosslinking fibrin  and  chains to stabilize the clot (Muszbek et al., 1999) . Besides its role in hemostasis, work in the last three decades has revealed its participation in wound healing and pregnancy maintenance (Gierhake et al., 1970; Asahina et al., 2000; Lorand, 2005) . A variety of mutations and splicing defects have been described in the FXIII subunit genes associated with bleeding tendency and plasma FXIII deficiency (Ichinose, 2001) . Most identified mutations involve subunit A, with very few mutations reported in subunit B (http://www.hgmd.cf.ac.uk/ac/index.php). The incidence of this disease, in the range of 1 in 5 million, is increasing as more laboratory support becomes available around the world. FXIII deficiency results in delayed bleeding after trauma and impaired wound healing, while primary hemostasis is apparently normal. Umbilical bleeding in the first days after birth, repeated intracranial hemorrhages and recurrent early miscarriages are characteristics of the disease.
The A subunit dimer, FXIII-A 2 , functions as an intracellular TG in the megakaryocyte/ platelet and monocyte/macrophage lineages where it can be activated by low Ca 2+ concentrations in the absence of thrombin (Polgar et al., 1990; Siebenlist et al., 2001; Adany and Bardos, 2003) . Platelets contain large amounts of the FXIII-A while the concentration in monocytes is at least one magnitude less than that in platelets (Muszbek et al., 1999) . This cellular form of FXIII (cFXIII) is assumed to regulate certain intracellular processes involving cytoskeleton remodeling during cell activation, but its precise role and the functional consequences of its absence remain poorly understood (Adany and Bardos, 2003) . Due to the severity of bleeding as a consequence of plasma FXIII deficiency, it has been difficult to determine whether patients with mutations in FXIII-A subunit have a distinctive phenotype associated to the concurrent lack of cellular FXIII.
In the last years several works have provided insights on the functional significance of the presence of FXIII-A in the monocyte/macrophage lineage. A recent study with FXIII-A-deficient monocytes suggests that it may play a role in Fc and complement receptor-mediated phagocytosis (Sarvary et al., 2004) . Further, it has been identified as a marker of alternative macrophage activation (Torocsik et al., 2005) . Moreover, the TG activity of cFXIII seems to play a role in receptor dimerization and increase of monocyte adhesion to endothelial cells at the onset of atherosclerosis (AbdAlla et al., 2004) . FXIII-A is also expressed in some subpopulations of dendritic cells (DCs) such as migratory dermal DCs (Nestle et al., 1993) , DC-like cells derived from CD34+ progenitor cells (Caux et al., 1996) , a subset of dermal cells termed ¨dermal dendrocytes¨ (Cerio et al., 1989; Quatresooz et al., 2008) , and in vitro monocyte-derived DCs (Grassi et al., 1998) . It has also been recently identified in a population of dermal cells with a marked plasticity between tissue-resident DCs and macrophages (Zaba et al., 2007) , suggesting that FXIII-A expression may associate to an alternative cellular activation state following the stimulation of DCs and macrophages by IL-4 (Nestle and Nickoloff, 2007) .
In the present report we first examined the relative expression of FXIII-A in monocytes and monocyte-derived DCs. Using this cellular model as well as stable cell transfectants, we analyzed the distribution pattern of FXIII-A and investigated whether it could have a role in regulating cell migration.
Materials and methods

Patient
The FXIII-deficient patient carried the Gly562Arg mutation in homozygosis in the A subunit. The absence of cFXIII was demonstrated by western and fluorescence microscopy analysis of platelets and dendritic cells. This mutation has been previously identified in other patient. Although normally synthesized, FXIII-A carrying Gly562Arg was reported to rapidly disappear in transfected cells, suggesting an altered conformation leading to rapid degradation (Takahashi et al., 1998) .
This study was approved by the hospital ethics Committee, and written informed consent for the use of blood sampling was obtained from the patient and controls in accordance with the Declaration of Helsinki.
PCR-based relative quantification of FXIII-A and TG2 mRNA
To determine the relative expression of FXIII-A in different human cell types, a series of 30 L-reverse transcription reactions were performed using the antisense oligonucleotide 5'-AGGATGCCATCTTCAAACTG-3'. Then, 5 L-aliquots were used as template in 20, 25, 30, and 35-cycle PCR reactions, using the sense oligonucleotide 5'-GTCTGTGCGGCTGTCCATC-3' to amplify a FXIII-A-cDNA fragment of 285-bp. Amplification of a 163-bp fragment of -actin-cDNA was carried out in parallel to verify that similar amounts of total RNA were used.
In order to compare the relative expression of FXIII-A and TG2 in monocytes and DCs, a series of 50 L-reverse transcription reactions were performed using random antisense oligonucleotides. 2 L-aliquots were used as template in 25, 30, 35 and 40-cycle PCR reactions using the antisense oligonucleotide described above that targets sequences shared by both TG2 and FXIII-A, and specific sense oligonucleotides, 5'-GTCTGTGCGGCTGTCCATC-3' and 5'-GCAAGACTGCACCTCG-3', to amplify 285-bp cDNA fragments of FXIII-A and TG2, respectively. The amplification products were then resolved on agarose gels, visualized by ethidium bromide staining, and analyzed by densitometry.
Cell culture and DC differentiation
Human PBMC were isolated from whole blood samples by Lymphoprep (Nycomed) gradient centrifugation. To obtain monocyte-enriched populations PBMC were allowed to adhere to serum-coated flasks for 1 h at 37ºC, or immuno-sorted using anti-CD41 coupled to magnetic microbeads (Milteny Biotec, Auburn, CA, USA). Monocytes were used to derive mature DCs as previously described (Sallusto and Lanzavecchia, 1994) . Briefly, cells at 0.5x10 6 /mL were cultured for 6-7 days in complete medium supplemented with GM-CSF (1000 U/mL) and IL-4 (1000 U/mL) (Immunotools, Friesoythe, Germany) every second day. Then, cytokines and LPS (0.5 μg/mL) (SIGMA) were added for an additional 36-h period to induce DC maturation.
Chinese hamster ovary (CHO) cells were transfected with FXIII-A-cDNA cloned into the pIRES2-EGFP expression vector using the calcium phosphate precipitation procedure. Transfected cells were grown in medium containing G-418 for three weeks, and clonal and pooled cell populations were isolated by cell sorting (FACS Vantage Cell Sorter, Becton Dickinson) and characterized for their FXIII-A protein expression levels using western and immunofluorescence microscopy analysis.
Cell migration assays
Transwell migration was determined by measuring the number of cells migrating through a polycarbonate filter (5-μm and 8-μm pore size for DCs and CHO cells, respectively) in 24-well transwell chambers (Costar Europe). 10 5 cells resuspended in 100 μL of media supplemented with 0.1% BSA were placed in the upper chamber and allowed to migrate to the lower chamber containing CCL19 (200 ng/mL) or 10% FCS, for DCs or CHO cells, respectively. After 2 h at 37ºC, cells in the lower chamber were counted by flow cytometry (Coulter flow cytometer model EPICS XL). CHO cells adhered to the lower side of the membrane were first harvested by incubation in PBS/EDTA. The percentage of migration was referred to the total number of cells in the input sample. For immunofluorescence detection of FXIII-A positive cells, the transwell filters were fixed and the cells stained as described in the next section.
For scratch-wound assays CHO cells were seeded into 24-well plates and cultured to nearly confluent cell monolayers. Cells were scratched using sterile pipette tips, washed with PBS, and incubated with medium supplemented with 1% FCS. Micrographs were taken at specific locations immediately after wounding and 3, 6, and 9 h later. Cell migration was quantified by measuring the distance between the wound edges before and after migration at three distinct positions using computer-assisted microscopy.
Fluorescence microscopy
Cells adhered to glass coverslips were fixed for 15 min in 4% paraformaldehyde in PBS, and blocked and permeabilized with 0.5% Triton X-100 in PBS-0.5% BSA for 20 min at room temperature. Then, cells were incubated with anti-FXIII-A polyclonal antibody (USBiological, Swanmpscott, MA, USA) and/or anti-vinculin mAb (SigmaAldrich) in PBS containing 0.1% Triton X-100 and 10% normal goat serum for 1 h. After washing with PBS, cells were incubated with Alexa Fluor 488-conjugated antirabbit and/or Alexa Fluor 647-conjugated anti-mouse antibodies. When indicated, Alexa Fluor 568 conjugated to phalloidin was added to simultaneously visualize F-actin. For nuclear staining, samples were incubated with DAPI (SIGMA) at 4 μg/mL in PBS for 15 min at room temperature. The preparations were mounted on FluorSave reagent (Calbiochem) and visualized with a x63 objective using a Zeiss Axioplan fluorescence microscope (Göttingen, Germany) equipped with a cooled CCD camera (Leica DFC 350 FX), or the Leica TCS-SP2-AOBS confocal microscope system.
Statistical analysis
The results are expressed as the means ± SE. Differences between experimental groups when we evaluated the effect of more than one factor were assessed using the Ftest for the analysis of the variance. The significance of the differences between two conditions was determined using the student's T-test for pair-wise comparisons. Significance was defined as p < 0.05.
Results
Up-regulation of FXIII-A expression during in vitro monocyte differentiation into DCs
We first analyzed the expression of cellular FXIII-A in different human cell types using a semi-quantitative RT-PCR assay. FXIII-A was not amplified in HEK-293 cells. In K562 myeloid cells, the mRNA was present in very limited amounts, appreciated only after 35 cycles. In contrast, FXIII-A was readily detected in monocytes, though at a concentration approximately one magnitude less than in platelets as previously reported (Muszbek et al., 1999) , and increased notably during the in vitro differentiation of monocytes to dendritic cells (DCs), where the expression levels relative to the -actinmRNA used as internal control was even higher than in platelets ( Figs 1A and B) .
Monocyte conversion into macrophages is accompanied by up-regulation of TG2, the most common TG family member (Murtaugh et al., 1983; Akimov and Belkin, 2001 ). Thus, we compared the relative expression of FXIII-A and TG2 in monocytes and DCs. As shown in Fig. 1C , FXIII-A and TG2 mRNA levels were very similar in monocytes, and differentiation to DCs was not associated with increased TG2 expression.
FXIII-A regulates migration of DCs
In order to explore the functional significance of FXIII-A up-regulation in monocytederived DCs, we analyzed the effect of monodansyl-cadaverine (MDC), a competitive amino-donor for TG activity (Parameswaran et al., 1990 ), on cell migration using a transwell assay. In these experiments, DCs were first induced to mature and, consequently, express CCR7, which is required for cell migration (Sallusto et al., 1998) . As shown in Fig. 2A , MDC inhibited both basal and CCL19-induced migration of DCs obtained from monocytes purified by either adhesion to serum-coated surfaces or immunomagnetic separation. Furthermore, FXIII-A-deficient DCs displayed normal endocytotic uptake of macromolecules like FITC-dextran particles (results not shown), but a significant reduction of transwell migration following CCL19 stimulation (Figs 2B and C) . Together, these findings suggest a role for FXIII-A-derived TG activity on the regulation of DC migration.
FXIII-A overexpression promotes cell migration
CHO cells stably expressing FXIII-A were established as an alternative approach to analyze whether FXIII-A expression correlates with migratory cell behavior. Cell migration, assessed by transwell assays, was found significantly improved in cellular clones with a high proportion (>80%) of cells expressing FXIII-A compared with untransfected cells (Fig. 3A) . To exclude clonal selection as a basis for the observed phenotypic difference, we analyzed individual cell migration in a pooled population with heterogeneous FXIII-A expression levels. Confocal microscopy analysis of the transwell membrane revealed a higher percent of cells expressing FXIII-A in layers corresponding to the lower side of the membrane, indicating that cell penetration through the membrane is enhanced in these cells (Fig. 3B) .
Scratch-wound assays were also carried out to compare migration of untransfected and FXIII-A-transfected cells. As shown in Fig. 4 , the rate of scratch closure was significantly higher in clonal cell populations expressing FXIII-A.
FXIII-A expression induces cell membrane blebbing
Because maturation of DCs is associated with a reduced ability to spread on coated surfaces (Burns et al., 2004) , we used immature DCs to analyze the localization pattern of FXIII-A. Confocal microscopy analysis revealed that, although broadly distributed, it shows a preferential localization in retracting uropods and membrane ruffles at the edges of protruding lamellae of migrating cells (Fig. 5A ). In addition, it was also abundant in actin-rich rounded projections expanding from the plasma membrane that could correspond to membrane protrusions referred to as blebs (Charras et al., 2006) (Fig. 5A) .
Expression of TG2 in a fibroblast cell line has been reported to induce cell morphology changes and membrane blebbing (Gentile et al., 1992) . Although plasma membrane blebs have been primarily associated with apoptotic and necrotic processes, recent evidences demonstrate its involvement in cell motility (Fackler and Grosse, 2008) . Thus, we found of interest to explore whether the increased migration observed in FXIII-A transfectants associated with the formation of plasma membrane blebs. Confocal microscopy analysis revealed that FXIII-A was present beneath the dorsal cell surface but not in optical sections that include the actin stress fiber-rich region in contact with the coverslip (Fig. 5B) . In addition, a high number of FXIII-A-expressing cells displayed membrane blebbing with FXIII-A showing an additional marked compartmentalization inside the blebs (Fig. 5B ). These membrane protrusions were also detected in FXIII-A-transfected cells migrating on two-dimensional surfaces (Fig. 4C) . Their structure preservation during fixation and the recruitment of actin to the surrounding membrane may indicate that they are retracting blebs (Fig. 5C ). In these cells, DAPI staining did not revealed changes in nuclear chromatin condensation related to cellular apoptotic or necrotic processes (results not shown).
Discussion
Dendritic cells (DCs) represent a heterogeneous population of professional antigenpresenting cells crucial for initiation and maintenance of T-cell-mediated immune responses. Immature DCs mainly home to areas of potential antigen entry, like skin and mucosa, where they exert a sentinel function taking up pathogens though pynocytosis and endocytosis (Banchereau and Steinman, 1998) . Migration to lymph nodes to prime T cells requires cell phenotypic maturation including up-regulation of the chemokine receptor CCR7 (Sallusto et al., 1998; Allavena et al., 2000; Riol-Blanco et al., 2005) . FXIII-A is expressed in different subsets of DCs including migratory dermal DCs (Nestle et al., 1993) and monocyte-derived DCs, which have a phenotype comparable to that of dermal DCs (Grassi et al., 1998) . Recently, it has been localized in a subset of dermal cells showing a marked plasticity between tissue-resident dendritic cells (DCs) and macrophages (Zaba et al., 2007) . In the present work, we show that FXIII-A mRNA is largely up-regulated during in vitro differentiation of human monocytes to DCs, reaching levels similar to those found in platelets. In contrast, the expression level of the most ubiquitous TG family member, TG2, did not change during this differentiation process, suggesting that TG activity in DCs basically relies on the presence of FXIII-A. However, expression of both TG2 and FXIII-A may account equally for TG activity in monocytes, in contrast with a previous report proposing FXIII-A as the predominant TG in these cells (Muszbek et al., 1988) . It is worthy to note that microbial stimulation of DCs has been recently shown to downregulate FXIII-A expression (Torocsik et al., 2005) ; however, FXIII-A protein was readily detected in the LPS-stimulated DCs used in our migratory assays.
So far, the functional significance of the high expression levels of FXIII-A in DCs remains elusive. In our study, a significant reduction of basal migration and chemotactic response to CCL19 was observed in DCs treated with the competitive TG inhibitor MDC, suggesting a role of cFXIII in regulating DC motility. Consistent with these data, the migratory response of FXIII-A-deficient DCs was reduced compared to that of control cells. It is known that intracellular rise of Ca 2+ concentration is sufficient to trigger activation of FXIII (Polgar et al., 1990) . Even though a rise in intracellular calcium appears to be dispensable for DC directional migration (Li et al., 2000) , the strong and sustained calcium mobilization induced by CCL19 (Humrich et al., 2006) may be directly linked to the role of FXIII-A in DC motility. On the other hand, TG activity of intracellular FXIII-A has been reported to crosslink agonist-induced AT1 receptor homodimers in human monocytes, which correlated with enhanced adhesion to endothelial cells (AbdAlla et al., 2004) . Whether this kind of mechanism could operate in other G-coupled protein receptors regulating specific receptor functions is unknown at the moment (Terrillon and Bouvier, 2004) . At the CCL19 concentration used in these experiments the chemotactic response of DCs has been demonstrated to completely depend on the chemokine receptor CCR7 (Riol-Blanco et al., 2005) . Thus, given the large upregulation of FXIII-A in monocyte-derived DCs, it is reasonable to consider the possibility that basal and/or stimulated TG activity could play a role in maintaining a level of CCR7 dimerization that, in turn, modulated the chemotactic response to CCL19.
A role for FXIII-A in cell motility is also supported by our results with a model of stably transfected cells. We show that overexpression of FXIII-A enhances cell migration in transwell and scratch-wound assays. Confocal microscopy analysis revealed that a significantly higher number of FXIII-A-expressing cells displayed membrane blebbing with FXIII-A residing inside the blebs. Localization of actin at the limiting membrane of the protrusion suggests that they are mainly retracting blebs. Blebs are dynamic spherical projections of the plasma membrane that are produced by local disruption of the membrane-actin cortex interaction (Charras et al., 2006) . Its precise function both in normal and pathological situations is still unclear. Although blebs have been often considered to be a feature of apoptotic and necrotic processes, they are also observed during normal cell spreading. As well, recent evidences support an important role of non-apoptotic membrane blebbing in cell motility, providing a common alternative to lamellipodia-based migration in three-dimensional environments (Charras and Paluch, 2008; Fackler and Grosse, 2008) . Signaling through Rho-ROCKmyosin has been demonstrated to be involved in bleb contractility (Charras et al., 2006; Fackler and Grosse, 2008) , but blebs can also be induced by a number of stimuli that disrupt membrane-actin cortex interactions (Fackler and Grosse, 2008) .
Extensive cell blebbing and fragmentation have been observed in transfected fibroblasts expressing high levels of TG2 (Gentile et al., 1992) . However, in the present study, the survival of blebbing cells and the apparent reversibility of blebs are compatible with its nonapoptotic nature. Interestingly, TG-induced transamidation and activation of RhoA is known to promote cytoskeletal rearrangement during neuronal differentiation (Singh et al., 2003) . In addition, platelet FXIII-A uses serotonin as a substrate to transamidate RhoA during platelet aggregation (Walther et al., 2003) . Thus, according to the distribution pattern of FXIII-A in our cell model, it is possible that local increases of TG activity triggered activation of the RhoA pathway at the site of blebbing.
The severe bleeding phenotype caused by plasma FXIII deficiency makes difficult to determine whether patients with mutations in FXIII-A subunit present concurrent symptoms associated to the lack of cellular FXIII. Monocytes lacking FXIII-A showed impaired receptor-mediated phagocytic activities (Sarvary et al., 2004) . In spite of this, increased susceptibility to infectious diseases has not been reported in patients with FXIII-A deficiency (Seitz et al., 1996) . Taken together, the herein reported data suggest that up-regulation of FXIII-A during DC differentiation may be crucially involved in migration of mature DCs. Thus, although further studies are required to determine the precise function of cFXIII in the monocyte/macrophage lineage, this study suggests that impaired motility of DCs may represent an additional factor contributing to the phenotype in FXIII-A-deficient patients. Cells were platted on serum-coated coverslips, and scratch-wound assay and epifluorescence microscopy analysis were carried out as described in "Materials and methods¨ after 6 h. 
